N Attal

Summary

Country: France

Publications

  1. ncbi [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]
    Sabine Clermont-Gnamien
    Service de Pharmacie, Hopital Ambroise Pare, Boulogne, France
    Presse Med 31:1840-5. 2002
  2. ncbi [Drug treatment for neuropathic pain]
    Nadine Attal
    INSERM U 792, F 92100 Boulogne Billancourt, France
    Presse Med 37:346-53. 2008
  3. ncbi Translating basic research on sodium channels in human neuropathic pain
    Nadine Attal
    Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, AP HP and Université Versailles Saint Quentin, France
    J Pain 7:S31-7. 2006
  4. ncbi EFNS guidelines on pharmacological treatment of neuropathic pain
    N Attal
    Centre d Evaluation at de Traitement de la Douleur, Hospital Ambroise Pare, Boulogne Billancourt, France
    Eur J Neurol 13:1153-69. 2006
  5. ncbi [Neuropathic pain: experimental advances and clinical applications]
    N Attal
    Centre d Evaluation et de Traitement de la Douleur et INSERM E 332 Hôpital Ambroise Paré, AP HP, Boulogne Billancourt et Université Versailles Saint Quentin
    Rev Neurol (Paris) 160:199-203. 2004
  6. ncbi Effects of surgery on the sensory deficits of syringomyelia and predictors of outcome: a long term prospective study
    N Attal
    INSERM E 332, Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, Boulogne Billancourt, France
    J Neurol Neurosurg Psychiatry 75:1025-30. 2004
  7. ncbi EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
    N Attal
    INSERM U 987, Centre dEvaluation et de Traitement de la Douleur, Hô pital Ambroise Paré, APHP, Boulogne Billancourt, France
    Eur J Neurol 17:1113-e88. 2010
  8. ncbi Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)
    N Attal
    Inserm U792, Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, AP HP, 9, avenue Charles de Gaulle, 92100 Boulogne Billancourt, France
    Ann Phys Rehabil Med 52:124-41. 2009
  9. ncbi Assessment of spinal somatosensory systems with diffusion tensor imaging in syringomyelia
    S M Hatem
    Inserm U792, CHUAmbroise Paré, APHP, Boulogne Billancourt, France
    J Neurol Neurosurg Psychiatry 80:1350-6. 2009
  10. ncbi Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation
    D Bouhassira
    Unité d évaluation et de traitement de la douleur, Hopital Ambroise Pare, Paris, France
    Pain 80:265-72. 1999

Collaborators

Detail Information

Publications26

  1. ncbi [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain]
    Sabine Clermont-Gnamien
    Service de Pharmacie, Hopital Ambroise Pare, Boulogne, France
    Presse Med 31:1840-5. 2002
    ..All the studies used administration of cannabis alone. The aim of this open, pilot, study was to assess the efficacy and side effect profile of oral dronabinol (tetrahydrocannabinol - THC) in the treatment of refractory neuropathic pain...
  2. ncbi [Drug treatment for neuropathic pain]
    Nadine Attal
    INSERM U 792, F 92100 Boulogne Billancourt, France
    Presse Med 37:346-53. 2008
    ..Studies show that pregabalin, gabapentin and duloxetine have positive effects that improve quality of life, and anxiety, depressive, and sleep disorders...
  3. ncbi Translating basic research on sodium channels in human neuropathic pain
    Nadine Attal
    Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, AP HP and Université Versailles Saint Quentin, France
    J Pain 7:S31-7. 2006
    ..To date, the role of sodium channels in neuropathic pain symptoms/signs is mostly documented for mechanical static and dynamic allodynia, and either peripheral or central sodium channels may be involved...
  4. ncbi EFNS guidelines on pharmacological treatment of neuropathic pain
    N Attal
    Centre d Evaluation at de Traitement de la Douleur, Hospital Ambroise Pare, Boulogne Billancourt, France
    Eur J Neurol 13:1153-69. 2006
    ..There are too few studies on central pain, combination therapy, and head-to-head comparison. For future trials, we recommend to assess quality of life and pain symptoms or signs with standardized tools...
  5. ncbi [Neuropathic pain: experimental advances and clinical applications]
    N Attal
    Centre d Evaluation et de Traitement de la Douleur et INSERM E 332 Hôpital Ambroise Paré, AP HP, Boulogne Billancourt et Université Versailles Saint Quentin
    Rev Neurol (Paris) 160:199-203. 2004
    ..Advances to date have not been spectacular although better tolerated agents have been recently marketed. Future progress should enable an appropriate response to the therapeutic challenge of neuropathic pain...
  6. ncbi Effects of surgery on the sensory deficits of syringomyelia and predictors of outcome: a long term prospective study
    N Attal
    INSERM E 332, Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, Boulogne Billancourt, France
    J Neurol Neurosurg Psychiatry 75:1025-30. 2004
    ..To quantify the effects of surgery on the thermal deficits of syringomyelia and assess the predictors for such effects...
  7. ncbi EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
    N Attal
    INSERM U 987, Centre dEvaluation et de Traitement de la Douleur, Hô pital Ambroise Paré, APHP, Boulogne Billancourt, France
    Eur J Neurol 17:1113-e88. 2010
    ..This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005...
  8. ncbi Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous)
    N Attal
    Inserm U792, Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, AP HP, 9, avenue Charles de Gaulle, 92100 Boulogne Billancourt, France
    Ann Phys Rehabil Med 52:124-41. 2009
    ..The aim of this review is to present evidence for efficacy and tolerability of pharmacological treatments in SCI pain and propose therapeutic recommendations...
  9. ncbi Assessment of spinal somatosensory systems with diffusion tensor imaging in syringomyelia
    S M Hatem
    Inserm U792, CHUAmbroise Paré, APHP, Boulogne Billancourt, France
    J Neurol Neurosurg Psychiatry 80:1350-6. 2009
    ....
  10. ncbi Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation
    D Bouhassira
    Unité d évaluation et de traitement de la douleur, Hopital Ambroise Pare, Paris, France
    Pain 80:265-72. 1999
    ....
  11. ncbi Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial
    P Azouvi
    Department of Neurological Rehabilitation, Raymond Poincare Hospital, Garches, France
    Brain Inj 13:797-804. 1999
    ..It is concluded that carbamazepine might help to reduce agitated behaviour in brain-injured patients. However, response to treatment demonstrated an important inter-individual variability...
  12. ncbi Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?
    N Attal
    INSERM U 792, Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, APHP, Boulogne Billancourt, F 92100, France
    Pain 138:343-53. 2008
    ....
  13. ncbi Painful diabetic neuropathy: diagnosis and management
    A Hartemann
    Service de Diabetologie, Hopital de la Pitie, AP HP, Universite Pierre et Marie Curie, 83, Boulevard de l Hopital, 75013 Paris, France
    Diabetes Metab 37:377-88. 2011
    ....
  14. ncbi Chronic neuropathic pain: mechanisms and treatment
    N Attal
    Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, Boulogne, France
    Clin J Pain 16:S118-30. 2000
    ..A mechanism-based approach seems promising for clinical research studies, although its application in current management remains challenging...
  15. ncbi Prevalence of chronic pain with neuropathic characteristics in the general population
    Didier Bouhassira
    INSERM U 792, Centre de Traitement et d Evaluation de la Douleur, CHU Ambroise Pare, 9, avenue Charles de Gaulle, Boulogne Billancourt cedex F 92100, France
    Pain 136:380-7. 2008
    ..We identified distinctive socio-demographic profile and clinical features indicating that chronic pain with neuropathic characteristics is a specific health problem...
  16. ncbi Comparison of the pain suppressive effects of clinical and experimental painful conditioning stimuli
    Didier Bouhassira
    INSERM E 332 Centre d Evaluation et de Traitement de la Douleur, Hopital Ambroise Pare, Boulogne Billancourt, France
    Brain 126:1068-78. 2003
    ..Thus, the mechanisms of counterirritation are not univocal, but depend on the pathophysiological mechanisms of clinical pain...
  17. ncbi Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain
    Danièle Ranoux
    Services de Neurologie, Neurochirurgie et Soins Palliatifs, Centre Hospitalier Universitaire de Limoges, Limoges, France
    Ann Neurol 64:274-83. 2008
    ..Botulinum toxin type A (BTX-A) has been reported to have analgesic effects independent of its action on muscle tone, possibly by acting on neurogenic inflammation. Such a mechanism may be involved in peripheral neuropathic pain...
  18. ncbi Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia
    Denis Ducreux
    Department of Neuroradiology, , AP-HP, , , France
    Brain 129:963-76. 2006
    ..The prefrontal cortex was the only area consistently activated by pathological evoked pains, suggesting that alteration of high-level pain modulatory mechanisms might play a major role in allodynia due to central lesion...
  19. ncbi Development and validation of the Neuropathic Pain Symptom Inventory
    Didier Bouhassira
    INSERM E 332, Center d Evaluation t de Traitement de la Douleur, Hôspiat Ambroise paré, Boulogne Billancourt, France
    Pain 108:248-57. 2004
    ....
  20. ncbi Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
    Didier Bouhassira
    INSERM E 332, AP HP Hôpital Ambroise Paré, Boulogne and Université Versailles Saint Quentin, France
    Pain 114:29-36. 2005
    ..The 10-item questionnaire developed in the present study constitutes a new diagnostic instrument, which might be helpful both in clinical research and daily practice...
  21. ncbi Using screening tools to identify neuropathic pain
    Michael I Bennett
    Clinical Teaching and Research Unit, St. Gemma's Hospice, 329 Harrogate Road, Leeds LS17 6QD, UK
    Pain 127:199-203. 2007
  22. ncbi Psychophysical study of the effects of topical application of menthol in healthy volunteers
    Samar Hatem
    INSERM, U792, CHU Ambroise Par, AP-HP, Boulogne-Billancourt F-92100, France
    Pain 122:190-6. 2006
    ..These data suggest that 30% menthol application may be a useful experimental model for studies of cold hyperalgesia in humans. The absence of local skin reactions also makes this test potentially suitable for use in patients...
  23. ncbi Towards a new taxonomy of idiopathic orofacial pain
    Alain Woda
    EA 3847, Faculte de Chirurgie Dentaire, CHU Clermont Ferrand 63000, France
    Pain 116:396-406. 2005
    ..These data provide grounds for an evidence-based classification of idiopathic facial pain entities and indicate that the current sub-classification of these syndromes relies primarily on the topography of the symptoms...
  24. ncbi Can pain be more or less neuropathic?
    Nadine Attal
    Pain 112:223-4. 2004
  25. ncbi Can pain be more or less neuropathic?
    Nadine Attal
    Pain 110:510-1. 2004
  26. ncbi Topical clonazepam in stomatodynia: a randomised placebo-controlled study
    Christelle Gremeau-Richard
    INSERM E 0216, , , CHU Clermont-Ferrand, Clermont-Ferrand 63000, France
    Pain 108:51-7. 2004
    ..It is hypothesised that clonazepam acts locally to disrupt the mechanism(s) underlying stomatodynia...